09.06.2017
- US active pharmaceutical ingredients (API) manufacturer Cambrex Corporation has announced the expansion of large-scale manufacturing capacity at its cGMP plant in Karlskoga, Sweden...
15.04.2015
- Swedish drugmaker Recipharm has acquired $2 million worth of preferred stock in Synthonics and has promised to buy an additional $2 million of the stock, contingent on the US metal...
